Self-reported alcohol intake and risk of acute exacerbations of chronic obstructive pulmonary disease: A prospective cohort study
Title
Self-reported alcohol intake and risk of acute exacerbations of chronic obstructive pulmonary disease: A prospective cohort study
Publication type
Journal Article
Year of Publication
2015
Authors
Journal
International Journal of COPD
Volume
10
Pagination
1363 - 1370
Date published
2015
ISBN
11769106 (ISSN)
Keywords
acute exacerbation chronic obstructive lung disease, Adult, Aged, alcohol, alcohol consumption, Alcoholism, article, azithromycin, beta 2 adrenergic receptor stimulating agent, Chronic obstructive, chronic obstructive lung disease, cohort analysis, controlled study, corticosteroid, drinking behavior, Ethanol, Female, hazard ratio, high risk patient, human, major clinical study, male, muscarinic receptor blocking agent, outcome assessment, patient assessment, placebo, prospective study, Pulmonary disease, questionnaire, randomized controlled trial, risk assessment, self report
Abstract
Objective: To evaluate the relationship between alcohol consumption and the risk of acute exacerbation of COPD (AECOPD). Methods and measurements: We conducted a secondary analysis of data previously collected in a large, multicenter trial of daily azithromycin in COPD. To analyze the relationship between amount of baseline self-reported alcohol consumption in the past 12 months and subsequent AECOPD, we categorized the subjects as minimal (<1 drink/month), light-to-moderate (1–60 drinks/month), or heavy alcohol users (>60 drinks/month). The primary outcome was time to first AECOPD and the secondary outcome was AECOPD rate during the 1-year study period. Results: Of the 1,142 enrolled participants, 1,082 completed baseline alcohol questionnaires and were included in this analysis. Six hundred and forty-five participants reported minimal alcohol intake, 363 reported light-to-moderate intake, and 74 reported heavy intake. There were no statistically significant differences in median time to first AECOPD among minimal (195 days), light-to-moderate (241 days), and heavy drinkers (288 days) (P=0.11). The mean crude rate of AECOPD did not significantly differ between minimal (1.62 events per year) and light-to-moderate (1.44 events per year) (P=0.095), or heavy drinkers (1.68 events per year) (P=0.796). There were no significant differences in hazard ratios for AECOPD after adjustment for multiple covariates. Conclusion: Among persons with COPD at high risk of exacerbation, we found no significant relationship between self-reported baseline alcohol intake and subsequent exacerbations. The number of patients reporting heavy alcohol intake was small and further study is needed to determine the effect of heavy alcohol intake on AECOPD risk.